Back
Compass Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
55
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.36
Seasonality Move:
2.61%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
The current trend is moderately bullish and CMPX is experiencing selling pressure, which indicates risk of future bearish movement.
Compass Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.4 | Buy |
| 20-day SMA: | 5.01 | Buy |
| 50-day SMA: | 4.37 | Buy |
| 200-day SMA: | 3.03 | Buy |
| 8-day EMA: | 5.35 | Buy |
| 20-day EMA: | 5.02 | Buy |
| 50-day EMA: | 4.48 | Buy |
| 200-day EMA: | 3.32 | Buy |
Compass Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 66.71 | Buy |
| Chaikin Money Flow: | -699240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.17 - 5.37) | Buy |
| Bollinger Bands (100): | (3.03 - 4.55) | Buy |
Compass Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics, Inc. Stock
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.53 while CMPX 8-day simple moving average is 5.40, which is a Buy signal.
-
The stock price of CMPX is 5.53 while Compass Therapeutics, Inc. 20-day SMA is 5.01, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day simple moving average is 4.37 while CMPX share price is 5.53, making it a Buy technically.
-
CMPX stock price is 5.53 and Compass Therapeutics, Inc. 200-day simple moving average is 3.03, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
55
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. a Buy or a Sell?
-
Compass Therapeutics, Inc. stock is rated a BuyThe current Compass Therapeutics, Inc. [CMPX] share price is $5.53. The Score for CMPX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics, Inc. Stock Info
Market Cap:
983.6M
Price in USD:
5.53
Share Volume:
1.1M
Compass Therapeutics, Inc. 52-Week Range
52-Week High:
5.86
52-Week Low:
1.33
Buy
55
Compass Therapeutics, Inc. (CMPX)
is a Buy
Compass Therapeutics, Inc. Share Price Forecast
-
What is the Compass Therapeutics, Inc. stock price today?The Compass Therapeutics, Inc. stock price is 5.53 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics, Inc. is not overvalued.
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.53 while CMPX 8-day exponential moving average is 5.35, which is a Buy signal.
-
The stock price of CMPX is 5.53 while Compass Therapeutics, Inc. 20-day EMA is 5.02, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day exponential moving average is 4.48 while CMPX share price is 5.53, making it a Buy technically.
-
CMPX stock price is 5.53 and Compass Therapeutics, Inc. 200-day simple moving average is 3.32, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics, Inc.
Is Compass Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.00 per share.
Technical Analysis of Compass Therapeutics, Inc.
Should I short Compass Therapeutics, Inc. stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Compass Therapeutics, Inc. is a Buy
-
Compass Therapeutics, Inc. Relative Strength Index (RSI) is 66.71, which suggest Compass Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Compass Therapeutics, Inc. is (4.17 - 5.37), which suggest Compass Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics, Inc. is (3.03 - 4.55), which suggest Compass Therapeutics, Inc. is a Buy
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.